ArticleKidney international reports2025

Refining Tolvaptan Dosing in ADPKD: The Role of Urinary Biomarkers in Enhancing Outcomes.

Liliana Italia De Rosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.